BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28867118)

  • 1. The Role of PET/MR Imaging in Precision Medicine.
    Huo E; Wilson DM; Eisenmenger L; Hope TA
    PET Clin; 2017 Oct; 12(4):489-501. PubMed ID: 28867118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers.
    Zukotynski KA; Kim CK
    PET Clin; 2017 Oct; 12(4):393-405. PubMed ID: 28867111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MR Imaging in Cardiovascular Imaging.
    Rischpler C; Woodard PK
    PET Clin; 2019 Apr; 14(2):233-244. PubMed ID: 30826021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Imaging of Small and Large Bowel.
    Das CJ; Manchanda S; Panda A; Sharma A; Gupta AK
    PET Clin; 2016 Jan; 11(1):21-37. PubMed ID: 26590441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
    Platzek I
    PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
    Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
    Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
    Zanotti-Fregonara P; Laforest R; Wallis JW
    J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection.
    Pawaskar A; Basu S; Jahangiri P; Alavi A
    PET Clin; 2019 Jan; 14(1):43-59. PubMed ID: 30420221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging.
    Roy S; Wang WT; Carass A; Prince JL; Butman JA; Pham DL
    J Nucl Med; 2014 Dec; 55(12):2071-7. PubMed ID: 25413135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
    Li W; Pang H; Liu Q; Zhou J
    Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
    Cerci JJ; Tabacchi E; Bogoni M
    PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
    Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
    Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.